Patient's Perspective on Psychiatric Drugs: A Multicenter Survey-Based Study.
暂无分享,去创建一个
J. Seo | W. Bahk | Y. Woo | B. Yoon | H. Song | Won Kim | I. Sohn | Kwanghun Lee | Jung Wan Hong | Seoyun Han | Sun-Young Kim | Young-Eun Jung | Jong Hun Lee | Sang-Keun Chung | Sang-Yeol Lee | Changwoo Han | Jhin Goo Chang | Minha Hong
[1] J. de Leon,et al. Adherence to psychiatric medications: Comparing patients with schizophrenia, bipolar disorder and major depression. , 2021, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.
[2] M. Mathews,et al. Patients’ Preference for Long-Acting Injectable versus Oral Antipsychotics in Schizophrenia: Results from the Patient-Reported Medication Preference Questionnaire , 2020, Patient preference and adherence.
[3] P. Talbot,et al. Medication nonadherence in bipolar disorder: a narrative review , 2018, Therapeutic advances in psychopharmacology.
[4] P. Weiden,et al. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia , 2018, BMC Psychiatry.
[5] P. Aslani,et al. Consumer-related factors influencing antidepressant adherence in unipolar depression: a qualitative study , 2018, Patient preference and adherence.
[6] W. Peñate,et al. To what extent is treatment adherence of psychiatric patients influenced by their participation in shared decision making? , 2014, Patient preference and adherence.
[7] J. Casoy,et al. Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia , 2013, Patient preference and adherence.
[8] T. Youn,et al. The Preference Survey for Long-Acting Injectable Antipsychotics of Community-Dwelling Patients with Schizophrenia and their Caregivers , 2013 .
[9] M. Sajatovic,et al. Medication treatment perceptions, concerns and expectations among depressed individuals with Type I Bipolar Disorder. , 2009, Journal of affective disorders.
[10] R. Drake,et al. Shared decision-making preferences of people with severe mental illness. , 2007, Psychiatric services.
[11] F. Johnson,et al. Factors That Affect Adherence to Bipolar Disorder Treatments: A Stated-Preference Approach , 2007, Medical care.
[12] G. Thornicroft,et al. Medication adherence in schizophrenia: exploring patients', carers' and professionals' views. , 2005, Schizophrenia bulletin.
[13] S. De Geest,et al. Adherence to Long-Term Therapies: Evidence for Action , 2003, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.
[14] Christian R. Dolder,et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. , 2002, The Journal of clinical psychiatry.
[15] R. Rosenheck,et al. Compliance with medication regimens for mental and physical disorders. , 1998, Psychiatric services.
[16] K. Demyttenaere. Compliance during treatment with antidepressants. , 1997, Journal of affective disorders.
[17] R S Woodward,et al. The effect of prescribed daily dose frequency on patient medication compliance. , 1990, Archives of internal medicine.
[18] Mitchell K. Byrne,et al. Treatment Adherence , 2021, Encyclopedia of Autism Spectrum Disorders.
[19] Kristin Decker. Diagnostic And Statistical Manual Of Mental Disorders Dsm 5 5th Edition , 2016 .
[20] Moon-Soo Lee,et al. Treatment compliance of antidepressants , 2010 .
[21] Anuja Roy,et al. Medication compliance and persistence: terminology and definitions. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.